Skip to main content
Premium Trial:

Request an Annual Quote

Immucor to Buy BioArray Solutions for $117M

NEW YORK (GenomeWeb News) — Diagnostics systems maker Immucor said Tuesday that it will buy molecular diagnostics company BioArray Solutions for around $117 million in cash. 
 
BioArray has developed diagnostic systems based on its BeadChip system to determine antigens for donors and recipients of blood transfusions. Immucor’s reagents and instruments also are focused on the blood transfusion industry.
 
Through the deal, Norcross, Ga.-based Immucor said it will acquire an IP portfolio with roughly 100 issued or pending patents.
 
BioArray will continue to operate out of its base in Warren, NJ, and will retain its name.
 
Immucor also said that BioArray’s current equity holders plan to form a new company before the deal closes that will commercialize the BioArray technologies outside of the blood transfusion and transplantation areas. That part of the deal will give Immucor a 19 percent holding in that new company.
 
Combined, the two companies should be able to “deliver more precise genotyping solutions to enhance patient outcomes,” and the deal should open up new opportunities in Immucor’s transplantation and transfusion-related applications, Immucor CEO Gioacchino De Chirico said in a statement.
 
BioArray CEO Michael Seul said that Immucor’s automated platforms, FDA licensing experience, distribution network, and financial backing should allow BioArray to introduce the BeadChip products more swiftly and widely than it would have been able to do otherwise.
 
Immucor said that it expects the acquisition to be dilutive to its earnings for several years following completion of the deal. For 2008, it said that the acquisition is expected to reduce its earnings per share by roughly $.20 to $.23.
 
In early Wednesday trade on the Nasdaq, Immucor’s shares tumbled 34 percent to $18.18.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.